RWM
GILD icon

Rialto Wealth Management’s Gilead Sciences GILD Stock Holding History

Rialto Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$149K Buy
1,071
+26
+2% +$3.64K 0.03% 175
2025
Q4 		$128K Buy
1,045
+6
+0.6% +$729 0.03% 188
2025
Q3 		$115K Buy
1,039
+7
+0.7% +$796 0.03% 189
2025
Q2 		$114K Buy
1,032
+15
+1% +$1.6K 0.03% 188
2025
Q1 		$114K Buy
1,017
+17
+2% +$1.75K 0.04% 181
2024
Q4 		$92.4K Buy
+1,000
New +$90K 0.03% 202

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Rialto Wealth Management's GILD Position: Q1 2026 in Review

Rialto Wealth Management increased its Gilead Sciences (GILD) stake by 2.5% in Q1 2026, buying an estimated $3.64K and bringing the position to 1,071 shares worth $149K. The position accounts for 0.03% of the portfolio, ranked #175.

Rialto Wealth Management first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Rialto Wealth Management held 1,071 shares of Gilead Sciences worth $149K as of Q1 2026.
  • Rialto Wealth Management bought 26 Gilead Sciences shares in Q1 2026, an estimated $3.64K.
  • Gilead Sciences made up 0.03% of Rialto Wealth Management's portfolio in Q1 2026, its #175 holding.
  • Rialto Wealth Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Rialto Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.